These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 5466693)

  • 1. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.
    Loring M; Schlesinger M
    Cancer Res; 1970 Aug; 30(8):2204-7. PubMed ID: 5466693
    [No Abstract]   [Full Text] [Related]  

  • 2. Time-lapse changes in the concomitant immunity of lymphoid cells from different regions of Ehrlich tumor-bearing mice and alterations in blastformation rate by PHA-stimulation.
    Orita K; Tomoyasu S; Kaneda S; Miwa H; Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):81-8. PubMed ID: 4268711
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance and susceptibility to tumours. VI. Reaction of labelled lymphoid cells transferred into the site of previously implanted carcinoma.
    Dvorák R; Lindner J
    Neoplasma; 1971; 18(1):63-86. PubMed ID: 5575435
    [No Abstract]   [Full Text] [Related]  

  • 4. Different behaviour of thymus in hosts bearing skin homografts or ehrlich ascites carcinoma.
    Simu G; Kiricuţă I; Crivii MS; Nestor D
    Arch Geschwulstforsch; 1976; 46(3):183-6. PubMed ID: 9920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance and susceptibility to tumours. 3. Effect of some derivatives from immunized animals on the Bo4 and Ehrlich carcinomas.
    Dvorák R; Chlumecký J
    Neoplasma; 1969; 16(6):613-24. PubMed ID: 5369028
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor factor of regional lymph node cells in the transplantation of Ehrlich tumor cells. 3. Passive transfer of the antitumor factor.
    Nakashima Y
    Acta Med Okayama (1952); 1969 Aug; 23(4):283-90. PubMed ID: 4243561
    [No Abstract]   [Full Text] [Related]  

  • 7. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-rosette forming lymphocytes in thymus, lymph nodes and in tumor from mice bearing syngeneic or allogeneic lymphoma.
    Conesa LG; Pasqualini CD; Astaldi G
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):458-63. PubMed ID: 737039
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro sensitization to transplantation antigens. I. Sensitization of lymphoid cells by allogeneic macrophages.
    Dyminski JW; Argyris BF
    Transplantation; 1971 Jun; 11(6):514-20. PubMed ID: 4931452
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation.
    Tanino T
    Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973
    [No Abstract]   [Full Text] [Related]  

  • 12. Action mechanism in vitro of sensitized regional lymph node cells on target cell. II. Difference in the biological effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11 cell).
    Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):99-117. PubMed ID: 4268713
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance and susceptibility to tumours. V. On the permeation of the 3H thymidine labelled cells from lymphatic organs into the site of proliferating tumour.
    Dvorák R; Lindner J
    Neoplasma; 1971; 18(1):41-62. PubMed ID: 5575434
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential effect of azathioprine on theta-antigenicity of mouse lymphocytes.
    Poulter LW; Bradley NJ; Turk JL
    Immunology; 1974 Apr; 26(4):777-85. PubMed ID: 4546773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of lymphocytes of animals sensitized against homologous tissue].
    Warnatz H; Scheiffarth F
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(3):277-81. PubMed ID: 4873611
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of transplantable murine "L-1210" leukemia growth with hemi-and allogeneic immunocytes.
    Schneiberg K; Rytwiński K; Bartnikowa W
    Pol Med Sci Hist Bull (1973); 1973; 15(6):597-604. PubMed ID: 4134227
    [No Abstract]   [Full Text] [Related]  

  • 18. A study on transplantation immunity of Ehrlich ascites tumor and methylcholanthrene-induced tumor in mice, with special reference to local immunity of lymph nodes draining the site of sensitization.
    Kitano M; Okada Y
    Bull Chest Dis Res Inst Kyoto Univ; 1968 Mar; 1(1):1-17. PubMed ID: 5678190
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the electrophoretic mobility of thymus, spleen and lymph node cells in tumor-bearing mice during dynamic tumor growth].
    Grinevich IuA; Fil'chakov FV; Alekseev SB; Kuz'menko AP
    Tsitologiia; 1989 Feb; 31(2):209-14. PubMed ID: 2734850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U; Slowikowska G; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.